|Publication number||US20040121454 A1|
|Application number||US 10/633,448|
|Publication date||Jun 24, 2004|
|Filing date||Aug 1, 2003|
|Priority date||Mar 10, 2000|
|Also published as||CA2400978A1, CN1441703A, EP1265708A1, EP1265708A4, US7485454, US20090275115, WO2001068257A1|
|Publication number||10633448, 633448, US 2004/0121454 A1, US 2004/121454 A1, US 20040121454 A1, US 20040121454A1, US 2004121454 A1, US 2004121454A1, US-A1-20040121454, US-A1-2004121454, US2004/0121454A1, US2004/121454A1, US20040121454 A1, US20040121454A1, US2004121454 A1, US2004121454A1|
|Inventors||Andrey Jury, Mark Angelino|
|Original Assignee||Bioprocessors Corp.|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (98), Referenced by (21), Classifications (46), Legal Events (1)|
|External Links: USPTO, USPTO Assignment, Espacenet|
 This application claims the benefit of priority under 35 U.S.C. §120 to U.S. patent application Ser. No. 09/707,852, filed Nov. 7, 2000, which application claims the benefit of priority under 35 U.S.C. §119(e) of U.S. Provisional Patent Application Serial No. 60/188,275, filed Mar. 10, 2000. These applications are incorporated herein by reference.
 The present invention relates generally to chemical or biochemical microreactors, and more particularly to a microreactor for the production of the product of a chemical or biochemical reaction, including a plurality of individuated microreactors constructed to operate in parallel.
 A wide variety of reaction systems are known for the production of the product of chemical or biochemical reactions. Chemical plants involving catalysis, biochemical fermenters, pharmaceutical production plants, and a host of other systems are well-known.
 Systems for housing chemical and biochemical reactions not necessarily for the production of product also are known. For example, continuous-flow systems for the detection of various analytes in bodily fluids including blood, such as oxygen, glucose, and the like are well known.
 In many of these and other systems, the capacity of the system (the volume of material that the system is designed to produce, process, or analyze) is adjusted in accordance with the volume of reactant, product, or analyte desirably processed or analyzed. For example, in large-scale chemical or pharmaceutical production, reactors are generally made as large as possible to generate as large a volume of product as possible. Conversely, in many areas of clinical diagnosis, where it is desirable to obtain as much information as possible from as small a physiological sample as possible (e.g., from a tiny drop of blood), it is a goal to minimize the size of reaction chambers of sensors. Several examples of small-scale reactor systems, including those used in clinical diagnoses and other applications, follow.
 U.S. Pat. No. 5,387,329 (Foos, et al.; Feb. 7, 1995) describes an extended use planar clinical sensor for sensing oxygen levels in a blood sample.
 U.S. Pat. No. 5,985,119 (Zanzucchi, et al.; Nov. 16, 1999) describes small reaction cells for performing synthetic processes in a liquid distribution system. A variety of chemical reactions including catabolic, anabolic reactions, oxidation, reduction, DNA synthesis, etc. are described.
 U.S. Pat. No. 5,674,742 (Northrup, et al.; Oct. 7, 1997) describes an integrated microfabricated instrument for manipulation, reaction, and detection of microliter to picoliter samples. The system purported by is suitable for biochemical reactions, particularly DNA-based reactions such as the polymerase chain reaction.
 U.S. Pat. No. 5,993,750 (Ghosh, et al.; Nov. 30, 1999) describes an integrated micro-ceramic chemical plant having a unitary ceramic body formed from multiple ceramic layers in the green state which are sintered together defining a mixing chamber, passages for delivering and reacting fluids, and means for delivering mixed chemicals to exit from the device.
 Biochemical processing typically involve the use of a live microorganism (cells) to produce a substance of interest. Biochemical and biomedical processing account for about 50% of the total drug, protein and raw amino-acid production worldwide. Approximately 90% of the research and development (R&D) budget in pharmaceutical industries is currently spent in biotechnology areas.
 Currently bioreactors (fermentors) have several significant operational limitations. The most important being maximum reactor size which is linked to aeration properties, to nutrient distribution, and to heat transfer properties. During the progression of fermentation, the growth rate for cells accelerates, and the measures required to supply the necessary nutrients and oxygen sets physical and mechanical constraints on the vessel within which the cells are contained. Powerful and costly drives are needed to compensate for inefficient mixing and low mass-transfer rates. Additionally, as metabolism of cells accelerates, the cells generate increased heat which needs to be dissipated from the broth.
 The heat transfer characteristics of the broth and the vessel (including heat exchanger) impose serious constraints on the reaction scale possible (see Table 1). While the particular heat load and power requirements are specific to the reaction, the scale of reaction generally approaches limitations at ˜10 m3 as in the case of E. coli fermentation (Table 1). The amount of heat to be dissipated becomes excessive due to limits on heat transfer coefficients of the broth and vessel. Consequently, the system of vessel and broth will rise in temperature. Unfortunately, biological compounds often have a relatively low upper limit on temperature for which to survive (<45° C. for many). Additionally, power consumption to disperse nutrients and oxygen and coolant requirements to control temperature make the process economically unfeasible (see Table 1).
TABLE 1 Oxygen- and Heat- Transfer Requirements for E. coli: Effects of Scale OTR (mmol/ Volumea Pressure Power Heat Load Coolantb L · h) (m3) (psig) (hp) (Btu/h) (° F.) 150 1 15 5.0 84 000 40 200 1 25 4.9 107 000 40 300 1 35 7.1 161 000 40 400 1 35 6.9 208 000 40 150 10 15 50.2 884 000 40 200 10 25 50.0 1 078 000 40 300 10 35 75.7 1 621 000 22 400 10 35 77.0 2 096 000 5
 Aside from reactor scalability, the design of conventional fermentors has other drawbacks. Due to the batch and semi-batch nature of the process, product throughput is low. Also, the complexity and coupled nature of the reaction parameters, as well as the requirement of narrow ranges for these parameters, makes control of the system difficult. Internal to the system, heterogeneity in nutrient and oxygen distribution due to mixing dynamics creates pockets in the broth characterized by insufficient nutrients or oxygen resulting in cell death. Finally, agitation used to produce as homogeneous a solution as possible (typically involving impellar string to simultaneously mix both cells and feeds of oxygen and nutrients) causes high strains which can fracture cell membranes and cause denaturation.
 While a wide variety of useful reactors for a variety of chemical and biological reactions, on a variety of size scales exist, a need exists in the art for improved reactors. In particular, there is a current need to significantly improve the design of bioreactors especially as the pharmaceutical and biomedical industries shift increasingly towards bioprocessing.
 The present invention provides systems, methods, and reactors associated with small-scale chemical or biochemical reactions.
 In one aspect the invention provides a chemical or biochemical reactor. The reactor includes a reaction unit including a chamber having a volume of less than one milliliter. The chamber includes an inlet connectable to a source of a chemical or biological starting material and an outlet for release of a product of a chemical or biological reaction involving the starting material. A collection chamber is connectable to the outlet of the reaction chamber. The collection chamber has a volume of greater than one liter.
 In another aspect the invention involves a chemical or biochemical reactor system. The system includes a mixing chamber including a plurality of inlets connectable to a plurality of sources of chemical or biochemical reagents, and an outlet. A reaction chamber is connectable to and removable from the mixing chamber, and has a volume of less than one milliliter. The reaction chamber includes an inlet connectable to and removable from the outlet of the mixing chamber, and an outlet for release of a product of a chemical or biological reaction involving the starting material.
 In another aspect the invention provides methods. One method includes carrying out a chemical or biological reaction in a plurality of reaction chambers operable in parallel, where each reaction chamber has a volume of less than one milliliter. Product of the reaction is discharged from the plurality of reaction chambers simultaneously into a collection chamber having a volume of greater than one liter.
 Other advantages, novel features, and objects of the invention will become apparent from the following detailed description of the invention when considered in conjunction with the accompanying drawings, which are schematic and which are not intended to be drawn to scale. In the figures, each identical or nearly identical component that is illustrated in various figures is represented by a single numeral. For purposes of clarity, not every component is labeled in every figure, nor is every component of each embodiment of the invention shown where illustration is not necessary to allow those of ordinary skill in the art to understand the invention.
FIG. 1 illustrates a microbioreactor of the invention including mixing, heating/dispersion, reaction, and separation units, in expanded view;
FIG. 2 illustrates the system of FIG. 1 as assembled;
FIG. 3 illustrates the mixing unit of the system of FIG. 1;
FIG. 4 is an expanded view of the heating/dispersion unit of the system of FIG. 1;
FIG. 5 is an expanded view of the reaction chamber of the system of FIG. 1; and
FIG. 6 is an expanded view of the separation unit of the system of FIG. 1.
 The present invention provides a chemical or biochemical reactor that can be used for a variety of very small-scale techniques. In one embodiment, a microreactor of the invention comprises a matrix of a few millimeters to a few centimeters in size containing reaction channels with dimensions on the order of hundreds of microns. Reagents of interest are allowed to flow through these microchannels, mixed, and reacted together. The products can be recovered, separated, and treated within the system. While one microreactor may be able only to hold and react a few microliters of the substances of interest, the technology allows for easy scalability and tremendous parallelization. With enhanced oxygen and nutrient distribution, a microreactor of the invention demonstrates increased performance in terms of cell viability. The microreactor geometry resembles closely the natural environment of cells whereby diffusional oxygen and nutrient transfer take place through a high surface area, thin layer interface.
 With regard to throughput, an array of many microreactors can be built in parallel to generate capacity on a level exceeding that allowed by current vessels and more uniform in product quality than can be obtained in a batch method. Additionally, an advantage is obtained by maintaining production capacity at the scale of reactions typically performed in the laboratory. In general, the coupled parameters for heat and mass transfer that are determined on the lab-scale for a process do not scale linearly with volume. With conventional reactors, as the magnitude of volume is increased 1,000-1,000,000 times for production, these parameters need to be re-evaluated, often involving a large capital-investment. The use of small production volumes, although scaled in parallel, reduces the cost of current scale-up schemes.
 Furthermore, the process can be implemented on a simple platform, such as an etched article for example, a silicon wafer. With the effort of semiconductor manufacturing being towards the reduction in the dimensions of channels, an opportunity to utilize excess capacity within these production facilities (with unused equipment for the larger dimensions) is provided. Mass production of these units can be carried out at very low cost and an array of many reactors, for example thousands of microreactors typically can be built for a price lower than one traditional bioreactor.
 Referring now to FIG. 1, a chemical or biochemical reactor in accordance with one embodiment of the invention is illustrated schematically. The reactor of FIG. 1 is, specifically, a microbioreactor for cell cultivation. It is to be understood that this is shown by way of example only, and the invention is not to be limited to this embodiment. For example, systems of the invention can be adapted for pharmaceutical production, hazardous chemical production, or chemical remediation of warfare reagents, etc.
 Microreactor 10 includes four general units. A mixing unit 12, a heating/dispersion unit 14, a reaction unit 16, and a separation unit 18. That is, in the embodiment illustrated, processes of mixing, heating, reaction, purification are implemented in series. Although not shown, pressure, temperature, pH, and oxygen sensors can be included, for example embedded within the network to monitor and provide control for the system. Due to the series format, the opportunity for several reaction units in series for multi-step chemical syntheses, for several levels of increased purification, or for micro-analysis units is provided as well.
FIG. 1 shows microreactor 10 in expanded view. As illustrated, each of units 14 and 16 (heating/dispersion and reaction units, respectively) includes at least one adjacent temperature control element 20-26 including a channel 28 through which a temperature-control fluid can be made to flow. As illustrated, temperature control units 20 and 24 are positioned above and below unit 14 and units 22 and 26 are positioned above and below unit 16. Separation unit 18 includes upper and lower extraction solvent fluid units 30 and 32, respectively, separated from unit 18 by membranes 34 and 36, respectively.
 Referring now to FIG. 2, reactor 10 is illustrated as assembled. The individual units of microreactor 10 will now be described in greater detail.
 Referring now to FIG. 3, mixing unit 12 is illustrated. Mixing unit 12 is designed to provide a homogeneous mixture of starting materials or reactants to be provided to the reaction units, optionally via the heating/dispersion unit. In the specific example of the microbioreactor, mixing unit 12 is designed to provide a homogeneous broth with sufficient nutrients and oxygen, and at the required pH, for cells. Rather than combine the mixing process with simultaneous nourishment of the cells, the process is performed in a preliminary stage and then fed to the reaction stage where cells are immobilized. In this manner, the cells do not experience any shear stress due to mixing and a homogeneous mixture of feed requirements is guaranteed.
 As is the case for other components of the reactor, mixing unit 12 can be manufactured using any convenient process. In preferred embodiments the unit is etched into a substrate such as silicon via known processes such as lithography. Other materials from which mixing unit 12, or other components of the systems of the. invention can be fabricated, include glass, fused silica, quartz, ceramics, or suitable plastics. Silicon is preferred. The mixing unit includes a plurality of inlets 40-50 which can receive any of a variety of reactants and/or fluid carriers. Although six inlets are illustrated, essentially any number of inlets from one to tens of hundreds of inlets can be provided. Typically, less than ten inlets are needed for a given reaction. Mixing unit 12 includes an outlet 52 and, between the plurality of inlets and the outlet, a mixing chamber 54 constructed and arranged to coalesce a plurality of reactant fluids provided through the inlets. It is a feature of the embodiment illustrated that the mixing chamber is free of active mixing elements. Instead, the mixing chamber is constructed to cause turbulence in the fluids provided through the inlets thereby mixing and delivering a mixture of the fluids through the outlet without active mixing. Specifically, the mixing unit includes a plurality of obstructions 56 in the flow path that causes mixture of fluid flowing through the flow path. These obstructions can be of essentially any geometrical arrangement. As illustrated, they define small pillars about which the fluid must turbulently flow as it passes from the inlets through the mixing chamber toward the outlet. As used herein “active mixing elements” is meant to define mixing elements such as blades, stirrers, or the like which are movable relative to the reaction chamber itself, that is, movable relative to the walls defining the reaction chamber.
 The volume of the mixing chamber, that is, the volume of the interior of mixing unit 12 between the inlets and the outlet, can be very small in preferred embodiments. Specifically, the mixing chamber generally has a volume of less than one liter, preferably less than about 100 microliters, and in some embodiments less than about 10 microliters. The chamber can have a volume of less than about five microliters, or even less than about one microliter.
 Specifically, in the microbioreactor illustrated, six separate feed streams empty into the mixing chamber under pressure. One feed stream provides gaseous oxygen (O2) as a cell requirement. One stream, respectively, provides carbon dioxide (CO2) and nitrogen (N2) for altering pH. The remaining three channels provide the broth solution including solvent and nutrients. One of these latter streams can also be utilized to provide any additional requirements for the system such as antifoaming agents. Antifoaming agents are sometimes necessary to prevent production of foam and bubbles that can damage cells within the broth. The feed of the various streams into the chamber provides enough turbulence for mixing of the different streams. Flow within microfluidic devices is characterized by a low Reynolds number indicating the formation of lamina. While the turbulence created by the injection streams should provide sufficient mixing before the development of laminar flow, pilon-like obstructions 56 are placed in the flow path of the stream leaving the primary mixing chamber in order to enhance mixing of the lamina. By splitting a main stream into substreams followed by reunification, turbulence is introduced in the flow path, and a mechanism other than simple diffusion is used to facilitate further mixing. The length of this mixing field can be lengthened or shortened depending on the system requirements.
 Referring now to FIG. 4, heating/dispersion unit 14 is shown. Unit 14 can be formed as described above with respect to other units of the invention. Unit 14 includes an inlet 60 in fluid communication with a plurality of outlets 62 in embodiments where dispersion as described below is desirable. In operation, a stream of homogeneous fluid exiting the mixing unit (feed broth in the specific microbioreactor embodiment shown) enters a dispersion matrix defined by a plurality of obstructions dividing the stream into separate flow paths directed toward the separate outlets 62. The dispersion matrix is sandwiched between two temperature control elements 20 and 24 which, as illustrated, include fluid flow channels 28 etched in a silicon article. Control unit 24 is positioned underneath unit 14, thus etched channel 28 is sealed by the bottom of unit 14. Control unit 20 is positioned atop unit 14 such that the bottom of unit 20 seals and defines the top of diffusion unit 14. A cover (not shown) can be placed a top unit 20 to seal channel 28.
 Rather than for mixing, as in the previous case (FIG. 3), the splitting of the streams is to disperse the medium for its entrance into the reactive chamber in the next unit operation. In traditional reactor systems, fluid flow about a packing material containing catalysts produces the desired reaction. However, if the fluid is not evenly dispersed entering the chamber, the fluid will flow through a low resistance path through the reactor and full, active surface area will not be utilized. Dispersion in this case is to optimize reactor efficiency in the next stage.
 With regard to the heating function of this unit, the platform functions as a miniaturized, traditional heat exchanger. Etched silicon platforms both above and below the central platform serve to carry a heated fluid. Cells typically require their environment to have a temperature of ˜30° C. The fluids flowing in the etched coils both above and below the broth flow channel heating the broth through the thin silicon layer. The temperature of the fluid in the upper and lower heat exchangers can be modified to ensure proper temperature for the broth. Additionally, the platform can be extended for increased heating loads.
 Although a combination heating/dispersion unit is shown, unit 14 can be either a dispersion unit or a heating unit. For example, dispersion can be provided as shown, without any temperature control. Alternatively, no dispersion need be provided (inlet 60 can communicate with a single outlet 62, which can be larger than the outlets as illustrated) and heating units can be provided. Cooling units can be provided as well, where cooling is desired. Units 20 and 24 can carry any temperature-control fluid, whether to heat or cool.
 Referring now to FIG. 5, reaction chamber 16 is shown, including temperature control units 22 and 26, in expanded form. Units 22 and 26 can be the same as units 20 and 24 as shown in FIG. 4, with unit 22 defining the top of reaction chamber 16. Reaction unit 16 includes an inlet 70 fluidly communicating with an outlet 72 and a reaction chamber defined therebetween. The reaction chamber, in microreactor embodiments of the invention, has a volume of less than one milliliter, or other lower volumes as described above in connection with mixing unit 12. Inlet 70 is connectable to a source of a chemical or biological starting material, optionally supplied by mixing unit 12 and heating/dispersion unit 14, and outlet 70 is designed to release the product of a chemical or biological reaction occurring within the chamber involving the starting material. Unit 16 can be formed from materials as described above.
 The reactor unit is the core of the process. While the unit is designed to be interchangeable for biological or pharmaceutical reactions, the specific application as shown is for cell cultivation. As in the case of the previous unit, temperature control units such as heat exchanger platforms will sandwich the central reaction chamber. The heat exchangers will maintain the temperature of the reaction unit at the same temperature as discussed for the cell broth.
 A feature of the unit is heterogeneous reaction on a supported matrix. Cell feed enters the reaction chamber under the proper pH, O2 concentration, and temperature for cell cultivation. Cells, immobilized onto the silicon framework at locations 74 either by surface functionalization and subsequent reaction or entrapment within a host membrane, metabolize the nutrients provided by the feed stream and produce a product protein. The initial reaction platform can be a two-dimensional array of cells both on the top and bottom of the reaction chamber. This arrangement is to prevent a large pressure drop across the unit which would be detrimental to flow.
 In this unit, oxygen and nutrients are diffused from the flowing stream to the immobilized cells. The cells, in turn metabolize the feed, and produce proteins which are swept away in the flowing stream. The flowing stream then enters the fourth chamber which removes the protein product from the solution.
 Referring again to FIG. 1, it can be seen how dispersion unit 14 creates an evenly-divided flow of fluid (reactant fluid such as oxygen and nutrients in the case of cell cultivation) across each of locations 74 in reaction to chamber 16.
 Referring now to FIG. 6, separation unit 18 is shown in greater detail, in expanded view. Separation unit 18 defines a central unit including an inlet 80 communicating with an outlet 82, and a fluid pathway 84 connecting the inlet with the outlet. Unit 18 can be fabricated as described above with respect to other components of the invention, and preferably is etched silicon. It may be desirable for fluid path 84 to completely span the thickness of unit 18 such that the pathway is exposed both above and below the unit. To maintain structural integrity, pathway 84 can be etched to some extent but not completely through unit 18 as illustrated, and a plurality of holes or channels can be formed through the bottom of the pathway exposing the bottom of the pathway to areas below the unit. Inlet 80 can be connectable to the outlet of reaction chamber 16, and outlet 82 to a container for recovery of carrier fluid.
 In the embodiment illustrated, membranes 34 and 36 cover exposed portions of fluid pathway 84 facing upward or downward as illustrated. Membranes 30 and/or 36 can be any membranes suitable for separation, i.e. extraction of product through the membrane with passage of effluent, or carrier fluid, through outlet 82. Those of ordinary skill in the art will recognize a wide variety of suitable membranes including size-selective membranes, ionic membranes, and the like. Upper and lower extraction solvent fluid units 30 and 32, which can comprise materials as described above including etched silicon, each include a fluid pathway 86 connecting an inlet 88 with an outlet 90. Fluid pathway 86 preferably is positioned in register with fluid pathway 84 of unit 18 when the separation unit is assembled. In this way, two flowing streams of solvent through channels 86 of units 30 and 32 flow counter to the direction of flow of fluid in channel 84 of unit 18, the fluids separated only by membranes 34 and 36. This establishes a counter-current tangential flow filtration membrane system. By concentration gradients, products are selectively extracted from channel 84 into solvent streams flowing within channels 86 of unit 30 or 32. Product is recovered through the outlet 90 of units 30 or 32 and recovered in a container (not shown) having a volume that can be greater than 1 liter. Outlets 90 thereby define carrier fluid outlets, and a fluid pathway connects inlet 80 of unit 18 with the carrier fluid outlets 90 of units 30 and 32, breached only by membranes 34 and 36. Carrier fluid outlet 82 can be made connectable to a recovery container for recycling of reaction carrier fluids. In the example of a microbioreactor, residual oxygen and nutrients are recovered from outlet 82 and recycled back into the feed for the process.
 The flowing streams of extraction solvent in channels 86 can be set at any desired temperature using temperature control units (not illustrated). In the case of a microbioreactor, these fluids can be set at approximately 4° C. The low temperature is needed to maintain the efficacy of the protein products and prevent denaturation. Additionally, several purification and clarification steps are often performed in industrial application. The necessity of further purification is remedied by the use of additional units in series.
 Embedded within the production process can be control systems and detectors for the manipulation of temperature, pH, nutrients, and oxygen concentration. Where a microbioreactor is used, the viability of cells is dependent upon strict limits for the parameters mentioned above. Narrow set-point ranges, dependent on the cell system selected, can be maintained using thermocouples, pH detectors, O2 solubility detectors, and glucose detectors between each unit. These measurements will determine the heat exchanger requirements, O2, CO2, N2, and nutrient inputs.
 Diaphragm and peristaltic pumps can be used to provide the necessary driving force for fluid flow in the units. Such pumps are also used to maintain flow in the heat exchanger units.
 It is a feature of the invention that many of the microreactors as illustrated can be arranged in parallel. Specifically, at least ten reactors can be constructed to operate in parallel, or in other cases at least about 100, 500, 1,000, or even 10,000 reactors can be constructed to operate in parallel. These reactors can be assembled and disassembled as desired.
 It is another feature of the invention that individual units 12, 14, 16, and 18 can be constructed and arranged to be connectable to and separable from each other. That is, any arrangement of individual components can be created for a desired reaction. For example, with reference to FIG. 1, heating/dispersion unit 14 may not be necessary. That is, outlet 52 of mixing unit 12 can be connectable to either inlet 60 of heating/dispersion unit 14, or inlet 70 of reaction unit 16 where a heating/dispersion unit is not used. Moreover, assembly and disassembly of reactors to create a system including many, many reactors operating in parallel, as described above, or in series is possible because of the connectability and separability of the components from each other to form systems containing specific desired components, and any number of those or other systems operating together. Equipment for connection and separation of individual components of a reactor can be selected among those known in the art, as can systems for connection of a variety of reactors in parallel or in series. Systems should be selected such that the individual components can be connectable to and separable from each other readily by laboratory or production-facility technicians without irreversible destruction of components such as welding, sawing, or the like. Examples of known systems for making readily reversible connections between components of reactors or between reactors to form parallel reactors or series reactors include male/female interconnections, clips, cartridge housings where components comprise inserts within the housings, screws, or the like.
 Those skilled in the art would readily appreciate that all parameters listed herein are meant to be exemplary and that actual parameters will depend upon the specific application for which the methods and apparatus of the present invention are used. It is, therefore, to be understood that the foregoing embodiments are presented by way of example only and that, within the scope of the appended claims and equivalents thereto, the invention may be practiced otherwise than as specifically described. In the claims the words “including”, “carrying”, “having”, and the like mean, as “comprising”, including but not limited to.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US4038151 *||Jul 29, 1976||Jul 26, 1977||Mcdonnell Douglas Corporation||Card for use in an automated microbial detection system|
|US4318994 *||Feb 26, 1981||Mar 9, 1982||Mcdonnell Douglas Corporation||Enterobacteriaceae species biochemical test card|
|US4720462 *||Nov 5, 1985||Jan 19, 1988||Robert Rosenson||Culture system for the culture of solid tissue masses and method of using the same|
|US4756884 *||Jul 1, 1986||Jul 12, 1988||Biotrack, Inc.||Capillary flow device|
|US4839292 *||Sep 11, 1987||Jun 13, 1989||Cremonese Joseph G||Cell culture flask utilizing a membrane barrier|
|US5219762 *||Dec 20, 1989||Jun 15, 1993||Mochida Pharmaceutical Co., Ltd.||Method and device for measuring a target substance in a liquid sample|
|US5278048 *||May 29, 1991||Jan 11, 1994||Molecular Devices Corporation||Methods for detecting the effect of cell affecting agents on living cells|
|US5387329 *||Apr 9, 1993||Feb 7, 1995||Ciba Corning Diagnostics Corp.||Extended use planar sensors|
|US5424209 *||Mar 19, 1993||Jun 13, 1995||Kearney; George P.||Automated cell culture and testing system|
|US5436129 *||Oct 12, 1993||Jul 25, 1995||Gene Tec Corp.||Process for specimen handling for analysis of nucleic acids|
|US5496697 *||Sep 8, 1993||Mar 5, 1996||Molecular Devices Corporation||Methods and apparatus for detecting the effect of cell affecting agents on living cells|
|US5534328 *||Dec 2, 1993||Jul 9, 1996||E. I. Du Pont De Nemours And Company||Integrated chemical processing apparatus and processes for the preparation thereof|
|US5595712 *||Jul 25, 1994||Jan 21, 1997||E. I. Du Pont De Nemours And Company||Chemical mixing and reaction apparatus|
|US5602028 *||Jun 30, 1995||Feb 11, 1997||The University Of British Columbia||System for growing multi-layered cell cultures|
|US5612188 *||Feb 10, 1994||Mar 18, 1997||Cornell Research Foundation, Inc.||Automated, multicompartmental cell culture system|
|US5632957 *||Sep 9, 1994||May 27, 1997||Nanogen||Molecular biological diagnostic systems including electrodes|
|US5639423 *||Aug 31, 1992||Jun 17, 1997||The Regents Of The University Of Calfornia||Microfabricated reactor|
|US5646039 *||Jun 6, 1995||Jul 8, 1997||The Regents Of The University Of California||Microfabricated reactor|
|US5705018 *||Dec 13, 1995||Jan 6, 1998||Hartley; Frank T.||Micromachined peristaltic pump|
|US5856174 *||Jan 19, 1996||Jan 5, 1999||Affymetrix, Inc.||Integrated nucleic acid diagnostic device|
|US5858770 *||Sep 30, 1997||Jan 12, 1999||Brandeis University||Cell culture plate with oxygen and carbon dioxide-permeable waterproof sealing membrane|
|US5916812 *||May 13, 1997||Jun 29, 1999||Biomerieux, Inc.||Test sample card with polymethylpentene tape|
|US5928880 *||Jun 11, 1997||Jul 27, 1999||Trustees Of The University Of Pennsylvania||Mesoscale sample preparation device and systems for determination and processing of analytes|
|US6012902 *||Sep 25, 1997||Jan 11, 2000||Caliper Technologies Corp.||Micropump|
|US6042710 *||May 11, 1999||Mar 28, 2000||Caliper Technologies Corp.||Methods and compositions for performing molecular separations|
|US6043080 *||Dec 11, 1998||Mar 28, 2000||Affymetrix, Inc.||Integrated nucleic acid diagnostic device|
|US6046056 *||Dec 6, 1996||Apr 4, 2000||Caliper Technologies Corporation||High throughput screening assay systems in microscale fluidic devices|
|US6167910 *||Jan 14, 1999||Jan 2, 2001||Caliper Technologies Corp.||Multi-layer microfluidic devices|
|US6171067 *||Oct 20, 1999||Jan 9, 2001||Caliper Technologies Corp.||Micropump|
|US6171850 *||Mar 8, 1999||Jan 9, 2001||Caliper Technologies Corp.||Integrated devices and systems for performing temperature controlled reactions and analyses|
|US6186660 *||Jul 26, 1999||Feb 13, 2001||Caliper Technologies Corp.||Microfluidic systems incorporating varied channel dimensions|
|US6193647 *||Apr 8, 1999||Feb 27, 2001||The Board Of Trustees Of The University Of Illinois||Microfluidic embryo and/or oocyte handling device and method|
|US6235175 *||Oct 2, 1998||May 22, 2001||Caliper Technologies Corp.||Microfluidic devices incorporating improved channel geometries|
|US6238538 *||Apr 6, 1999||May 29, 2001||Caliper Technologies, Corp.||Controlled fluid transport in microfabricated polymeric substrates|
|US6245295 *||Feb 23, 1999||Jun 12, 2001||Bio Merieux, Inc.||Sample testing apparatus with high oxygen permeable tape providing barrier for closed reaction chamber|
|US6251343 *||Feb 24, 1998||Jun 26, 2001||Caliper Technologies Corp.||Microfluidic devices and systems incorporating cover layers|
|US6264892 *||Jan 11, 2000||Jul 24, 2001||Agilent Technologies, Inc.||Miniaturized planar columns for use in a liquid phase separation apparatus|
|US6267858 *||Jun 24, 1997||Jul 31, 2001||Caliper Technologies Corp.||High throughput screening assay systems in microscale fluidic devices|
|US6338790 *||Apr 21, 1999||Jan 15, 2002||Therasense, Inc.||Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator|
|US6346413 *||Nov 17, 1999||Feb 12, 2002||Affymetrix, Inc.||Polymer arrays|
|US6368871 *||Aug 13, 1997||Apr 9, 2002||Cepheid||Non-planar microstructures for manipulation of fluid samples|
|US6377721 *||Mar 2, 1999||Apr 23, 2002||Trustees Of Tufts College||Biosensor array comprising cell populations confined to microcavities|
|US6410309 *||Nov 28, 2000||Jun 25, 2002||Biocrystal Ltd||Cell culture apparatus and methods of use|
|US6509085 *||Apr 10, 2000||Jan 21, 2003||Caliper Technologies Corp.||Fabrication of microfluidic circuits by printing techniques|
|US6517234 *||Nov 2, 2000||Feb 11, 2003||Caliper Technologies Corp.||Microfluidic systems incorporating varied channel dimensions|
|US6551841 *||Jan 27, 1999||Apr 22, 2003||The Trustees Of The University Of Pennsylvania||Device and method for the detection of an analyte utilizing mesoscale flow systems|
|US6569674 *||Jan 26, 2000||May 27, 2003||Amersham Biosciences Ab||Method and apparatus for performing biological reactions on a substrate surface|
|US6582576 *||Oct 7, 1999||Jun 24, 2003||Caliper Technologies Corp.||Controller/detector interfaces for microfluidic systems|
|US6592821 *||May 10, 2001||Jul 15, 2003||Caliper Technologies Corp.||Focusing of microparticles in microfluidic systems|
|US6597438 *||Aug 2, 2000||Jul 22, 2003||Honeywell International Inc.||Portable flow cytometry|
|US6689594 *||Jun 4, 1999||Feb 10, 2004||Haenni Claude||Device for organic cell culture and for studying their electrophysiological activity and membrane used in said device|
|US6716588 *||Dec 8, 2000||Apr 6, 2004||Cellomics, Inc.||System for cell-based screening|
|US6716620 *||Mar 26, 2001||Apr 6, 2004||Purdue Research Foundation||Biosensor and related method|
|US6716629 *||Oct 10, 2001||Apr 6, 2004||Biotrove, Inc.||Apparatus for assay, synthesis and storage, and methods of manufacture, use, and manipulation thereof|
|US6742661 *||Aug 17, 2001||Jun 1, 2004||Micronics, Inc.||Well-plate microfluidics|
|US6756019 *||Apr 6, 2000||Jun 29, 2004||Caliper Technologies Corp.||Microfluidic devices and systems incorporating cover layers|
|US6837927 *||Jan 29, 2002||Jan 4, 2005||Syrrx, Inc.||Microvolume device employing fluid movement by centrifugal force|
|US6857449 *||Sep 30, 2003||Feb 22, 2005||Caliper Life Sciences, Inc.||Multi-layer microfluidic devices|
|US20020029814 *||Apr 6, 2001||Mar 14, 2002||Marc Unger||Microfabricated elastomeric valve and pump systems|
|US20020055166 *||Oct 2, 2001||May 9, 2002||Cannon Thomas F.||Automated bioculture and bioculture experiments system|
|US20020068358 *||Apr 5, 2001||Jun 6, 2002||Campbell Michael J.||In vitro embryo culture device|
|US20020072116 *||Oct 12, 2001||Jun 13, 2002||Bhatia Sangeeta N.||Nanoporous silicon bioreactor|
|US20020086439 *||Oct 17, 2001||Jul 4, 2002||Caliper Technologies Corp.||Integrated devices and systems for performing temperature controlled reactions and analyses|
|US20020092767 *||Nov 28, 2001||Jul 18, 2002||Aclara Biosciences, Inc.||Multiple array microfluidic device units|
|US20020097633 *||Jan 11, 2002||Jul 25, 2002||Nanostream,Inc.||Multi-stream microfluidic mixers|
|US20030008308 *||Apr 5, 2002||Jan 9, 2003||California Institute Of Technology||Nucleic acid amplification utilizing microfluidic devices|
|US20030008388 *||Jun 25, 2002||Jan 9, 2003||Biocrystal, Ltd.||Cell culture apparatus and methods of use|
|US20030010104 *||May 16, 2002||Jan 16, 2003||Byeong-Wook Jeon||Learning method for an automatic transmission of a vehicle and a system thereof|
|US20030013203 *||Jul 29, 2002||Jan 16, 2003||Zyomyx||Microfluidic devices and methods|
|US20030015429 *||Sep 3, 2002||Jan 23, 2003||Caliper Technologies Corp.||Methods, devices and systems for characterizing proteins|
|US20030022153 *||Mar 15, 2002||Jan 30, 2003||Gregory Kirk||Method of monitoring haptotaxis|
|US20030022197 *||Mar 15, 2002||Jan 30, 2003||Greg Kirk||Device for monitoring haptotaxis|
|US20030022203 *||Apr 23, 2002||Jan 30, 2003||Rajan Kumar||Cellular Arrays|
|US20030022269 *||Mar 15, 2002||Jan 30, 2003||Gregory Kirk||Method of monitoring cell motility and chemotaxis|
|US20030022362 *||Mar 15, 2002||Jan 30, 2003||Gregory Kirk||Cell motility and chemotaxis test device and methods of using same|
|US20030026740 *||Aug 5, 2002||Feb 6, 2003||Staats Sau Lan Tang||Microfluidic devices|
|US20030049862 *||May 24, 2002||Mar 13, 2003||Lin He||Microcolumn-based, high-throughput microfluidic device|
|US20030077817 *||Apr 10, 2002||Apr 24, 2003||Zarur Andrey J.||Microfermentor device and cell based screening method|
|US20030082632 *||Jul 23, 2002||May 1, 2003||Cytoprint, Inc.||Assay method and apparatus|
|US20030082795 *||Apr 25, 2002||May 1, 2003||Michael Shuler||Devices and methods for pharmacokinetic-based cell culture system|
|US20030104512 *||Nov 30, 2001||Jun 5, 2003||Freeman Alex R.||Biosensors for single cell and multi cell analysis|
|US20030129665 *||Aug 29, 2002||Jul 10, 2003||Selvan Gowri Pyapali||Methods for qualitative and quantitative analysis of cells and related optical bio-disc systems|
|US20030134431 *||Oct 24, 2002||Jul 17, 2003||Caliper Technologies Corp.||High throughput screening assay systems in microscale fluidic devices|
|US20030142291 *||Nov 26, 2002||Jul 31, 2003||Aravind Padmanabhan||Portable scattering and fluorescence cytometer|
|US20040002131 *||Mar 12, 2003||Jan 1, 2004||Enoch Kim||Cell motility and chemotaxis test device and methods of using same|
|US20040029213 *||Jun 7, 2001||Feb 12, 2004||Callahan Daniel E.||Visual-servoing optical microscopy|
|US20040029266 *||Aug 9, 2002||Feb 12, 2004||Emilio Barbera-Guillem||Cell and tissue culture device|
|US20040053403 *||Jun 24, 2003||Mar 18, 2004||Zyomyx||Microfluidic devices and methods|
|US20040058407 *||Jun 5, 2003||Mar 25, 2004||Miller Scott E.||Reactor systems having a light-interacting component|
|US20040058408 *||Aug 28, 2003||Mar 25, 2004||Gyros Ab||Microfabricated apparatus for cell based assays|
|US20040058437 *||Jun 5, 2003||Mar 25, 2004||Rodgers Seth T.||Materials and reactor systems having humidity and gas control|
|US20040067577 *||Oct 8, 2002||Apr 8, 2004||Wilson Wilbur W.||Micro-fluidic device for monitoring biomolecular interactions|
|US20040072278 *||Apr 1, 2003||Apr 15, 2004||Fluidigm Corporation||Microfluidic particle-analysis systems|
|US20040077075 *||May 1, 2003||Apr 22, 2004||Massachusetts Institute Of Technology||Microfermentors for rapid screening and analysis of biochemical processes|
|US20050014129 *||Aug 6, 2002||Jan 20, 2005||David Cliffel||Device and methods for detecting the response of a plurality of cells to at least one analyte of interest|
|US20050037471 *||Apr 30, 2004||Feb 17, 2005||California Institute Of Technology||Microfluidic rotary flow reactor matrix|
|US20050047967 *||Sep 3, 2003||Mar 3, 2005||Industrial Technology Research Institute||Microfluidic component providing multi-directional fluid movement|
|US20050089993 *||Apr 1, 2004||Apr 28, 2005||Paolo Boccazzi||Apparatus and methods for simultaneous operation of miniaturized reactors|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US7276351||Oct 17, 2003||Oct 2, 2007||Seahorse Bioscience||Method and device for measuring multiple physiological properties of cells|
|US7638321||Jun 1, 2007||Dec 29, 2009||Seahorse Bioscience, Inc.||Method and device for measuring multiple physiological properties of cells|
|US7795359||Mar 1, 2006||Sep 14, 2010||Novartis Ag||Continuous process for production of polymeric materials|
|US7851201||Nov 9, 2009||Dec 14, 2010||Seahorse Bioscience, Inc.||Method and device for measuring multiple physiological properties of cells|
|US8119079 *||Mar 24, 2008||Feb 21, 2012||Samsung Electronics Co., Ltd.||Microfluidic apparatus having fluid container|
|US8202702||Oct 14, 2009||Jun 19, 2012||Seahorse Bioscience||Method and device for measuring extracellular acidification and oxygen consumption rate with higher precision|
|US8658349||Jul 13, 2006||Feb 25, 2014||Seahorse Bioscience||Cell analysis apparatus and method|
|US8697431||May 19, 2010||Apr 15, 2014||Seahorse Bioscience, Inc.||Method and device for measuring multiple physiological properties of cells|
|US9138745 *||Feb 8, 2013||Sep 22, 2015||Rohm Co., Ltd.||Microchip|
|US20030077817 *||Apr 10, 2002||Apr 24, 2003||Zarur Andrey J.||Microfermentor device and cell based screening method|
|US20040197905 *||Jan 16, 2004||Oct 7, 2004||Thermogenic Imagining||Methods and devices for monitoring cellular metabolism in microfluidic cell-retaining chambers|
|US20050054028 *||Oct 17, 2003||Mar 10, 2005||Thermogenic Imaging||Method and device for measuring multiple physiological properties of cells|
|US20060019333 *||Jun 7, 2005||Jan 26, 2006||Rodgers Seth T||Control of reactor environmental conditions|
|US20060241242 *||Mar 1, 2006||Oct 26, 2006||Devlin Brian G||Continuous process for production of polymeric materials|
|US20070087401 *||Oct 10, 2006||Apr 19, 2007||Andy Neilson||Analysis of metabolic activity in cells using extracellular flux rate measurements|
|US20110041986 *||Feb 24, 2011||Dai Nippon Printing Co., Ltd.||Micro-reactor and method of manufacturing the same|
|US20110220332 *||Mar 12, 2010||Sep 15, 2011||Analogic Corporation||Micro channel device temperature control|
|US20130209329 *||Feb 8, 2013||Aug 15, 2013||Rohm Co., Ltd.||Microchip|
|EP1905505A2 *||Sep 26, 2007||Apr 2, 2008||FUJIFILM Corporation||Method of manufacturing an emulsion, and emulsion so produced|
|WO2004065618A2 *||Jan 14, 2004||Aug 5, 2004||Thermogenic Imaging||Methods and devices for monitoring cellular metabolism in microfluidic cell-retaining chambers|
|WO2007098027A2 *||Feb 15, 2007||Aug 30, 2007||Bioprocessors Corp||Microreactor with auxiliary fluid motion control|
|U.S. Classification||435/288.5, 435/289.1|
|International Classification||C12M1/00, C12P21/00, G01N37/00, B01J19/24, B81B1/00, C12P1/00, B81B7/04, G01N33/53, B01F13/00, B01F5/02, B01F5/06, B01J19/00, C12M3/00|
|Cooperative Classification||B01J2219/00957, B01J2219/00835, B01J2219/00873, B01F5/0647, B01F13/0094, B01F5/0256, B01J2219/00783, B01F2005/0621, B01J2219/00961, B01J2219/00966, B01J2219/00828, B01J2219/00871, B01J2219/00907, B01J2219/00963, B01F5/061, B01J19/0093, B01F15/00935, C12M23/16, B01J2219/00862, B01F5/0646, B01F13/0064, B01J2219/00889|
|European Classification||B01F13/00M6J, B01F15/00T2, B01F5/06B3F2, C12M23/16, B01F5/06B3F, B01F5/06B3B, B01F13/00M2B, B01J19/00R, B01F5/02C|
|May 20, 2005||AS||Assignment|
Owner name: STARLAB N.V./S.A., BELGIUM
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:JURY, ANDREY ZARUR;REEL/FRAME:016267/0491
Effective date: 20001219
Owner name: STARLAB N.V./S.A., BELGIUM
Free format text: NUNC PRO TUNC ASSIGNMENT;ASSIGNOR:ANGELINO, MARK D.;REEL/FRAME:016267/0474
Effective date: 20031030
Owner name: BIOPROCESSORS CORP., CALIFORNIA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:STARLAB, N.V./S.A.;REEL/FRAME:016267/0479
Effective date: 20001218